comparemela.com

Latest Breaking News On - Chimeric antigen receptor cart cell therapy - Page 1 : comparemela.com

Afamitresgene autoleucel as an effective T-cell therapy for synovial sarcoma and liposarcoma

1. Overall response rate to afami-cel in both groups was 37%. 2. The majority of adverse-events were moderate in nature with no treatment-related deaths. Evidence Rating Level: 1 (Excellent) Study Rundown: Synovial sarcoma and myxoid round cell liposarcoma are rare, chemo-refractory malignancies with a poor prognosis once metastasized. Current treatment regimens are limited, and a

CAR T-Cell Therapy - Novel Form of Immunotherapy

CAR T-cell therapy is a type of gene therapy where the patient’s T-lymphocytes are genetically altered to target cancer cells within the patient’s body.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.